Bioreactors Market Size 2024-2028: Insights and Growth Forecast

The bioreactors market is projected to grow significantly by USD 2.23 billion, at a CAGR of 6.99%, from 2023 to 2028. Several companies in the market are offering innovative accessories and improved features to strengthen their position. These accessories not only enhance the functionality of bioreactors but also help companies retain their customers and attract new ones. For instance, Infors offers various accessories such as LabCIP, Exit Gas Analysis, Spin Filter, and Super Safe Sampler that aid in bioreactor maintenance and improve its performance. As a result, the adoption of bioreactors is rising, contributing to market growth.

For more details about the industry, get the PDF sample report for free

Segment Overview

The bioreactors market is segmented as follows:

End-user Outlook:

• Biopharmaceutical Companies
• Research Institutes
• Contract Research Organizations

Type Outlook:

• Automated
• Manual

Geography Outlook:

• North America: The U.S., Canada
• Europe: The U.K., Germany, France, Rest of Europe
• Asia: China, India,
• Rest of the World: Australia, Argentina, Brazil

Market Segmentation by End-user, Type, and Geography

End-user Analysis:

• Biopharmaceutical Companies: The biopharmaceutical companies segment is estimated to see substantial growth during the forecast period. The rising prevalence of chronic diseases across the globe is driving the need for high-quality, regulatorily compliant drugs and therapeutic treatments. Bioreactors play a crucial role in drug discovery and development, such as in the screening and production of therapeutically relevant compounds. This segment was the largest in 2018, valued at USD 1.90 billion, as bioreactors are widely used in various biomanufacturing processes, including media preparation, filtration, viral clearance, and cell harvesting. These processes are essential for producing monoclonal antibodies, vaccines, and therapeutic proteins, boosting segment growth.

Type Analysis:

• Automated: The automated bioreactor segment is gaining traction due to its use in the biopharmaceutical industry for the production of biologics, such as therapeutic proteins, monoclonal antibodies, and vaccines. Automated systems offer controlled, consistent production processes, ensuring higher product yields and improved quality.
• Manual: Manual bioreactors are increasingly used in academic and research settings to teach bioprocess engineering and biotechnology. Their flexibility and adaptability make them suitable for various cell lines, experimental setups, and research conditions. They provide researchers greater control over bioprocessing, thus propelling market growth in this segment.

Market Dynamics - Drivers, Trends, and Challenges

Key Market Drivers:

• Increased Collaborations: The market is experiencing significant growth due to an increase in collaborations among stakeholders. Many bioreactor manufacturers are partnering with companies to leverage their unique selling points, expanding their customer base, technology, and financial capabilities. Such collaborations are positively impacting market growth.

Significant Market Trends:

• Value-added Software Services: Companies are incorporating additional software and hardware products to provide greater value to customers. For example, SOLARIS BIOTECHNOLOGY offers the Leonardo data viewer, a software designed for optimizing media, parameters for cultivation, and performing trial runs. This software helps in analyzing data and monitoring the cultivation process, thus enhancing productivity and driving market growth.

Major Market Challenges:

• Ethical Issues in Stem Cell Bioprocessing: The bioreactors market faces challenges related to the ethical concerns surrounding the use of stem cells in regenerative medicine. The use of human embryonic stem cells, cloning, and the destruction of embryos raises significant ethical issues. These concerns are hindering the market's growth, especially in research related to regenerative medicine.

Get more details by ordering the complete report

Key Bioreactors Market Players

Several market players are leveraging strategic alliances, partnerships, and mergers to strengthen their market presence. The key players in the bioreactors market include:

• Automated Engineering Services Inc
• Bioengineering AG
• BPC Instruments AB
• Cell Culture Co. LLC
• Danaher Corp.
• Distek Inc.
• Donaldson Co. Inc.
• Eppendorf SE
• Getinge AB
• Infors AG
• LAMBDA CZ sro
• Merck KGaA
• PBS Biotech Inc.
• Pierre Guerin SA
• Sartorius AG
• Solida Biotech GmBH
• Thermo Fisher Scientific Inc.
• Zellwerk GmbH
• ZETA
• 3D Biotek LLC

This comprehensive market report provides insights into the bioreactors industry, focusing on market dynamics, trends, and key players to help businesses navigate the competitive landscape during the forecast period from 2024 to 2028.